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Abstract 
Dendritic cells (DCs) are the most potent antigen-presenting cells and play a crucial role in 
the regulation of immune response and migration of DCs into secondary lymphoid tissues also 
play an important role in the initiation of innate and adaptive immunity. Radiation therapy is 
now a routine treatment for certain types of cancer and over 20 percent of cancer patients 
will require radiation therapy during the treatment of their disease. However, the influence of 
ionizing irradiation on the migratory ability of DCs is largely unknown. In this article, we 
report that  ray irradiation can significantly inhibit LPS-triggered up regulation of CCR7 
expression and PGE2 production by DC, thus impairing DC migration towards CCL19 in 
vitro and in vivo. Moreover,  ray exposed DC also displayed an increased apoptosis rate and 
decreased cell viability. Furthermore, we demonstrate that exogenous PGE2 can partly re-
duce the gamma-ray induced migratory impairment and restored CCR7 expression of DC. 
Our work suggests that  irradiation affects DC function at multiple steps during the immune 
response including DC migration, and that PGE2, via control of CCR7 expression, is an 
important regulator of DC migration. 
Key words:  ray Irradiation, Dendritic cell; Migration; CCR7; Apoptosis. 
1. Introduction 
Dendritic  cells  (DCs,  DC)  are  the  most  potent 
antigen-presenting cells (APC) and play a critical role 
in immune regulation, ranging from tolerance induc-
tion and the prevention of autoimmunity, to the in-
duction  of  anti-tumor  immunity  and  the  protection 
against infectious agents [1-4]. Genetic tagging shows 
DCs are specialized and regulated antigen processing 
machines and they play critical role in epidermal viral 
immunity  [5-7].  In-activation  of  host  DCs  can  also 
prevent graft versus host disease in animal model [8, 
9]. From ex vivo loading to in vivo targeting of DCs 
have  developed  many  pharmacological  targets  of 
immunosuppressive  drugs  in  immunotherapy  [10, 
11]. 
DCs originate from bone marrow precursors and 
migrate  through  the  blood  stream  to  almost  every 
tissue, where they reside in an immature state. Studies 
also show that Langerhans cells can renew in the skin 
throughout life under steady-state condition [12]. At 
the site of an infection, DCs recognize and respond to 
common  pathogen-associated  molecular  patterns 
(PAMP), including lipopeptides, lipopolysaccharides Int. J. Biol. Sci. 2011, 7 
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(LPS) and nucleic acids via Toll-like receptors (TLR) 
[13-15]. LPS activates DC and induces production of 
pro-inﬂammatory cytokines and other mediators via 
TLR4,  thus  triggering  a  complex  phenotypic  and 
functional  maturation  program  of  DC  including 
up-regulation of the chemokine receptor CCR7 [16]. 
The CCR7 upregulation enables an increased respon-
siveness of DC to CCR7 ligands, which promotes DC 
migration from peripheral tissues to secondary lym-
phoid  organs  such  as  lymph  nodes  (LN)  and  the 
spleen where DC present antigens to T cells and initi-
ate immune response [17]. The expression of CCR7 on 
mature DC is essential for their migration to the T-cell 
area of draining LN because this migration is guided 
by two ligands for CCR7, CCL19 (EBI1-ligand chem-
okine  [ELC],  macrophage  inﬂammatory  protein 
[MIP]-3),  and  CCL21  (secondary  lymphoid-tissue 
chemokine [SLC], 6-Ckine), Both chemokines are ex-
pressed by stromal cells in the T-cell area of secondary 
lymphoid organs [18]. The essential role of CCR7 and 
its  ligands  in  mature  DC  migration  to  LN  was 
demonstrated  in  CCR7  deficient  mice  and  plt/plt 
mice, which lack the ligands for CCR7 [17]. Because 
the migration of DC into secondary lymphoid organs 
is required for the  initiation  of specific immune re-
sponses,  inhibition  of  DC  migration  into  secondary 
lymphoid organs by inhibiting CCR7 expression is an 
efficient way to induce immunosuppression and tol-
erance.  PGE2,  derived  from  the  metabolism  of  free 
arachidonic acid, exerts an important immunomodu-
latory  role  in  DC  differentiation  and  function  [19]. 
Previous studies have shown that PGE2 is required 
for  CCR7-expressed  DC  migration  to  its  ligands, 
CCL19 and CCL21, and the importance of PGE2 for 
DC  migration  in  vivo  has  also  been  shown  in 
Ptger4−/−  mice lacking the  PGE2 receptor EP4 [20, 
21]. These mice display impaired migration of Lang-
erhans cells and reduced skin immune responses. 
With  the  development  of  clinical  radiation 
therapy and the nuclear industry, the ionizing radia-
tion (IR) hazards to human health have attracted more 
and more attention [22, 23]. It is generally accepted 
that ionizing radiation is capable of causing cellular 
damage, immune-suppression and even cell death of 
many  cell  types,  including  immune  cells  [23].  The 
effect  of  IR  on  T  and  B  cells  has  been  extensively 
studied; however the influence of ionizing irradiation 
on DC function is largely unknown. In particular, the 
role of -irradiation on the migratory abilities of DC, is 
still not clear. Therefore, a study of radiation effects on 
DC migration would be very important. 
In this study, we demonstrate that  - irradiation 
can significantly inhibit LPS-triggered upregulation of 
CCR7 expression and PGE2 production by DC, thus 
impairing DC migration towards CCR7 ligand CCL19 
in vitro and in vivo. Moreover,  ray exposed DC also 
display an increased apoptosis rate and reduced cell 
viability which also promotes the migration impair-
ment induced by IR. Most importantly,  we demon-
strate that exogenous PGE2 partly reduces the gam-
ma-ray  induced  migratory  impairment  and  restores 
the  CCR7  expression  of  DC,  but  don’t  affect  the 
apoptosis level of DC. Our work suggests that - irra-
diation affects DC function at multiple steps during 
the immune response, including DC migration, and 
that PGE2, via control of CCR7 expression, is an im-
portant regulator of DC migration. 
2. Materials and Methods 
2.1 Mice and reagents 
Male wild-type C57BL/6 mice, 5–6 weeks of age, 
were  purchased  from  Chinese  academy  of  science 
(Shanghai, China). All mice were housed in a patho-
gen-free  facility  for  all  experiments.  All  animal  ex-
periments  were  undertaken  in  accordance  with  the 
National Institute of Health Guide for the Care and 
Use of Laboratory Animals, with the approval of the 
Laboratory Animal Center of Second Military Medical 
University, Shanghai. The approval ID for this study 
was 20090101. All efforts were made to minimize the 
number  of  animals  used  as  well  as  their  suffering. 
Recombinant mouse GM-CSF, IL-4 and CCL19 were 
purchased  from  Peprotech  Systems  (rocky  Hill,  NJ, 
Minneapolis,  MN).  PE-labeled  CCR7  Ab  was  pur-
chased from ebioscience (San Diego, CA). ELISA kits 
for  murine  PGE2  and  IL-10  were  purchased  from 
R&D  Systems  (Minneapolis,  MN).  Lipopolysaccha-
ride  (LPS)  were  from  Sigma  Company  (USA).  Cell 
viability  kits  (CCK8)  and  CFSE  were  from  Dojindo 
Laboratories  (Kumamoto,  Japan)  and  Annexin 
V-FITC  and  propidium  iodide  Apoptosis  Detection 
Kits  were  from  Bipec  Biopharma,  (Massachusetts, 
USA.) 
2.2 Generation of mouse bone marrow 
(BM)-derived DC  
Mouse immature DC was prepared from bone 
marrow progenitors according to published method 
of  our  university  with  minor  modifications  [17,  24, 
25]. Bone marrow mononuclear cells were prepared 
from  murine  (5-6  weeks  old)  femur  bone  marrow 
suspensions by depletion of red cells, and then cul-
tured at a density of 2x106 cells/ml in 6-well plates in 
RPMI1640  medium  supplemented  with  10%  FCS, 
10ng/ml recombinant  murine GM-CSF and 1ng/ml 
recombinant  murine  IL-4  (peprotech  Systems). 
Non-adherent  cells  were  gently  washed  out  on  the 
third day of culture; the remaining loosely adherent Int. J. Biol. Sci. 2011, 7 
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clusters were used on day 5 as immature DC. On day 
5, cells were exposed to gamma-rays and treated with 
LPS  (1ug/ml,  24hours)  according  to  a  published 
method [20, 21]. 
2.3 Gamma Irradiation 
A 60Co theratron (Fyc－50H) machine was used 
to deliver the radiation (Irradiation Center, Faculty of 
Naval Medicine, Second Military Medical University, 
China) DCs were exposed to different doses of radia-
tion,  (Dose  rate:  1Gy/min)  depending  upon  the  re-
quirement  of  the  study  according  to  our  published 
method [26-28].  
2.4 In vitro DC chemoattraction assay 
To evaluate the responsiveness of  ray exposed 
DC to CCL19 (macrophage inﬂammatory protein-3), 
an in vitro chemoattraction assay was performed in 
24-well transwell chambers with 5µm-pore size poly-
carbonate  ﬁlters  (Corning  Costar,  Cambridge,  MA). 
100 ng/ml CCL19 diluted in RPMI 1640 containing 
0.5%  bovine  serum  albumin  (BSA)  were  added  to 
lower wells in a volume of 0.6 mL; 0.1 mL RPMI 1640 
containing 2×105 DC was added to the upper wells 
and chambers incubated for 4 hours at 37°C. Directed 
migration was expressed as the number of cells that 
had  migrated  to  the  lower  chamber,  as  counted  by 
FACS as described previously [20, 21]. 
2.5 In vivo DC migration assays 
DC were labeled with 5 μM carboxyfluorescein 
diacetate succinimidyl ester (CFSE; Dojindo, Japan) in 
PBS at 37°C for 30 minutes and washed twice imme-
diately  before  i.v.  injection  into  C57BL/6  mice.  24 
hours later, the skin of injected cite and the draining 
inguinal  LN  were  harvested  and  processed  as  de-
scribed previously [17, 24, 25]. Single cell suspensions 
were prepared, stained with CD11c-PE (eBioscience) 
and analyzed by flow cytometry. 
2.6 Assay for CCR7 expression 
Prior  to  fluorescent  antibody  staining,  all  cells 
were incubated with CD16/CD32 antibody at a con-
centration of 1µg/106cells/100µl for 15 minutes at 4oC 
to  block  Fc  receptors.  Fluorescent  antibodies 
(CCR7-PE,  ebioscience)  and  respective  isotype  con-
trols  were  then  added  at  a  concentration  of 
1µg/106cells/100µl, and cells incubated for a further 
30 minutes at 4°C. The cells were washed once with 
ice-cold PBS (pH 7.2) containing 0.1% NaN3 and 0.5% 
BSA, and resuspended in 300ml PBS. Flow cytometry 
was performed using a FACS Calibur and data ana-
lyzed  using  CellQuest  software  (both  from  Becton 
Dickinson, Mountain View, CA) according to a pub-
lished method [20, 25]. 
2.7 ELISA assay 
 IL-10 and PGE2 contained in the culture super-
natants  of  DC  with  or  without    ray  exposure  and 
before or without LPS stimulation were measured by 
ELISA  (R&D,  Minneapolis,  MN)  according  to  the 
manufacturer’s  instructions  and  some  published 
method [25]. 
2.8 Apoptosis assay.  
After  different  treatments,  DCs  were  labeled 
with annexin V-FITC and propidium iodide (PI) pro-
vided  by  BIPEC,  following  manufacturer’s  instruc-
tions.  Samples  were  examined  by  ﬂuores-
cence-activated  cell  sorter  (FACS)  analysis,  and  the 
results  were  analyzed  using  Cell-Quest  software 
(Becton Dickinson, San Jose, CA) [25]. 
2.9 Cell Viability Analyses  
Trypan  blue  exclusion  test  were  used  for  de-
tecting cell viability as previously described. Briefly, 
after  different  treatments,  DCs  were  labeled  with 
Trypan Blue. The cellular morphology was observed 
using  Olympus  BX60  fluorescent  microscope 
equipped with Retiga 2000R digital camera. Average 
percentage of Trypan Blue positives and negative cells 
were calculated in 5-7 randomly selected high power 
field (HPF). Trypan Blue negative cells were regarded 
as living cells. Alternatively, cell viability was deter-
mined by MTT assay and CCK8 assay (cell counting 
kit  8,  Dojindo  Laboratories,Kumamoto,  Japan). 
Measuring the optical density (OD) at 450 nm with 
microtiter plate reader, we calculated cell viability by 
standard curve. 
2.10 Statistical analysis 
 Comparisons between experimental groups and 
relevant controls were performed by Student’s t-test. 
P < 0.05 was considered a statistically significant dif-
ference.  
3. Results  
3.1 -ray exposure inhibits CCL19 induced DC 
migration in a dose dependent way  
One characteristic of mature DC is their ability to 
migrate  to  secondary  lymphoid  organs  where  DC 
present  antigens  to  T  cells  and  initiate  an  immune 
response [20, 21]. Therefore, inhibition of DC migra-
tion to secondary lymphoid organs is an efficient way 
to induce immunosuppression and tolerance. To con-
firm whether ionizing radiation affects DC migration, 
we examined in vitro migration of DC toward CCL19, 
the chemokine chemotactic for mature DC. As can be 
seen  from  figure  1,  LPS-matured  DC  responded  to 
CCL19 much more efficiently than immature DCs (0 Int. J. Biol. Sci. 2011, 7 
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Gy, P<0.05; Figure 1A). In contrast, after pre-exposure 
to  irradiation, LPS-matured DC responded less well 
to CCL19 (Figure 1A). Interestingly, -irradiation in-
hibited  LPS  -induced  DC  migration  to  CCL19  in  a 
dose dependent manner. In a time course study sys-
tem, DC were pre-exposed to 2 Gy of  rays irradiation 
or left unexposed, and then 0, 2, 6, 12, 24, 48 and 72 
hours later, the migration capacity of these DC was 
detected  by  FACS  analysis.  Time  course  study 
showed that -irradiation inhibited DC migration to 
CCL19 in a time related manner (Figure 1B and 1C). 
Thus, -ray exposure inhibits CCL19 induced DC mi-
gration in a dose and time related way. 
 
 
Figure 1. Effect of  radiation exposure on DC migration. DC with different treatment were subjected to an in vitro 
chemoattraction assay to evaluated their migration capacity to CCL19 as described detailed in Materials and Methods 
section and in many other previously studies [20, 21]. Each experiment was performed in triplicate and repeated at least 
three times. Data is expressed as mean number of migrated DC cells; ±S.D. (A): DC were treated with or without  ray 
irradiation (Dose 0, 2, 4, 8Gy as indicated, Dose rate: 1Gy/min) with or without LPS (1ug/ml) for 24 hours. Then these DC 
were subjected to in vitro chemoattraction assay to detect their migration capacity. (B): DC were treated with or without 
2 Gy  ray irradiation (Dose rate: 1Gy/min) with or without LPS (1ug/ml) for the indicated time (0,2,6,12, 24, 48 and 72 
hours). Then these DC were subjected to in vitro chemoattraction assay to detect their migration capacity. (C) : DC were 
treated with or without 2 Gy  ray irradiation (Dose rate: 1Gy/min) and then after further incubation for the indicated time 
(0,2,6,12, 24, 48 and 72 hours), these DC were treated with LPS (1ug/ml) for another 24 hours and then they were subjected 
to in vitro chemoattraction assay to detect their migration capacity by FACS assays. *: P < 0.05. 
 
 
3.2 -irradiation inhibits LPS-induced CCR7 ex-
pression and PGE2, IL10 secretion by DC  
It's well known that LPS induces maturation of 
DC with up-regulation of CCR7 which binds to the 
ligand CCL19 and directs DC migration to secondary 
lymph organs, a process critical for DC to initiate an 
immune response. PGE2,  derived from the  metabo-
lism  of  free  arachidonic  acid,  exerts  an  important 
immunomodulatory  role  in  DC  differentiation  and 
function [17]. Prostaglandin E2 may be the key factor 
for CCR7 surface expression and migration of mono-
cyte-derived dendritic cells [20]. Additionally, IL-10 
may also down-regulate CCR7 expression by myeloid Int. J. Biol. Sci. 2011, 7 
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dendritic cells. To confirm that the reduced migration 
of DC by -irradiation is associated with the inhibited 
CCR7 expression and altered PGE2 and IL10 produc-
tion, we investigated FACS assay to study CCR7 ex-
pression and ELISA assay for PGE2 and IL10 in  ray 
exposed  DC  with  or  without  LPS  stimulation.  DC 
were  pre-exposed  to    rays  or  left  unexposed,  and 
then stimulated with LPS (1ug/ml) for 24 h for FACS 
analysis of the cell and ELISA assay of the superna-
tant.  Gamma-irradiation  significantly  inhibited 
LPS-induced CCR7 expression in DC (Figure 2 A and 
B).  Similarly,  in  a  time  course  study  system,  2Gy 
Gamma-irradiation also significantly inhibited CCR7 
expression in DC in a time related manner (Figure 2 
C).  These  data  indicate  the  impaired  LPS-induced 
up-regulation of CCR7 expression in  ray-treated DC 
may  account  for  their  impaired  migratory  ability. 
LPS-induced PGE2 and IL10 production by DC were 
also been found to be significantly inhibited by  ray 
in a dose and time related manner (Figure 3 A and B). 
This suggests that  ray irradiation can significantly 
inhibit LPS triggered up-regulation of CCR7 expres-
sion by down regulation of PGE2 production by DC, 
thus impairing DC  migration towards CCR7 ligand 
CCL19 in vitro, while IL10 may not participate in the 
IR induced migration impairment of DC.  
 
 
Figure 2. Gamma-radiation down-regulated CCR7 expression by DC in a time and dose related manner. DC with 
different treatment was labeled with CCR7-PE antibody for detection of the CCR7 positive cell percent by FACS assays. 
Each experiment was performed in triplicate and repeated at least three times. Data is expressed the mean CCR7 positive 
cell rate±S.D. *: P < 0.05; NS: No Significant difference detected. (A/B) : DC were treated with or without  ray irradiation 
(Dose 0, 2, 4, 8Gy as indicated, Dose rate: 1Gy/min) with or without LPS (1ug/ml) for 24 hours and then the CCR7 positive 
cell rate in these DC were detected by FACS assay. A showed a representative data of at least three independent ex-
periments. B showed the statistical data. (C) : DC were treated with or without 2 Gy  ray irradiation (Dose rate: 1Gy/min) 
and then after further incubation for the indicated time (0,2,6,12, 24, 48 and 72 hours), these DC were treated with LPS 
(1ug/ml) for another 24 hours and then the CCR7 positive cell rate in these DC were detected by FACS assay. *: P < 0.05. Int. J. Biol. Sci. 2011, 7 
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Figure 3. Gamma-irradiation down-regulated PGE2 and IL10 secretion by DC. The supernatant of DC with different 
treatment was collected and subjected to ELISA assay for detection of the PGE2 and IL10 level. (A): DC were treated with 
or without  ray irradiation (Dose 0, 2, 4, 8Gy as indicated, Dose rate: 1Gy/min) with or without LPS (1ug/ml) for 24 hours 
and then the PGE2 and IL10 level in the culture supernatant were detected by ELISA assay. (B): DC were treated with or 
without 2 Gy  ray irradiation (Dose rate: 1Gy/min) and then after further incubation for the indicated time (0,2,6,12, 24, 48 
and 72 hours), these DC were treated with LPS (1ug/ml) for another 24 hours and the PGE2 and IL10 level in the culture 
supernatant were detected by ELISA assay. *: P < 0.05. 
 
3.3 Exogenous PGE2 partly rescues the  
ray-induced migratory impairment of DC and 
restores CCR7 expression.  
To  further  investigate  the  role  of  the  reduced 
PGE2 in  ray mediated inhibition of DC migration, 
we  added  exogenous  PGE2  into  the  DC  migration 
assay,  and  found  the  addition  of  exogenous  PGE2 
(1uM) partially restored the migratory capacity of   
ray  -treated  DC  in  chemo-attraction  assays  (Figure 
4A).  We  also  found  that  exogenous  PGE2  partially 
restored  CCR7  expression  in    ray  treated  and 
LPS-stimulated  DC  (Figure  4B).  These  results  are 
consistent with reports [20] showing that PGE2 regu-
lates  the  expression  of  CCR7  in  DC  and  influences 
their migration. However, we also found that PGE2 
restores CCR7 expression much more effectively than 
it rescues of migratory impairment of DC induced by 
IR; PGE2 also acts more effectively on DC irradiated 
at 2Gy than 8Gy (Figure  4C). These results suggest 
that the inhibition of DC migration by  ray may be 
partially  due  to  its  inhibition  of  PGE2  production, 
which in turn results in a defective CCR7 expression 
in DC, thus leading to the impaired migration of DC 
to CCL19. However, there must be other mechanisms 
also involved in  ray induced DC migration impair-
ment. 
3.4  ray induced apoptosis also participates in 
DC migration impairment.  
To confirm whether ionizing radiation affects the 
DC  apoptosis  rate,  we  examined  in  annexinV-FITC 
and  propidium  iodide  (PI)  double  staining  assay to 
determine the apoptosis rate of DC. We also used cell 
count assays to inspect DC cell viability. As expected, 
IR  can  induce  DC  apoptosis  in  a  dose  dependent 
manner (Figure 5 A and B). Gamma irradiation can 
also  inhibit  DC  cell  viability  in  a  dose  dependent 
manner (Figure 5C). These data suggest that  radia-
tion can induce DC apoptosis and inhibit DC viability 
in a dose dependent manner. 
To confirm that gamma ray induced apoptosis 
also  participates  in  DC  migration  impairment,  we Int. J. Biol. Sci. 2011, 7 
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next used FACS assay to value the apoptosis rate of 
migrated  DC  and  not-migrated  DC  after  different 
dose of irradiation (migrated DC means the DC that 
have  migrated/transwelled  in  a  transwell  assay; 
not-migrated  DC  means  the  DC  that  have  not  mi-
grated/transwelled in a transwell assay). We found 
that migrated DC show a much lower apoptosis rate 
than  not-migrated  DC  in  every  group  (Figure  6A). 
Indeed, the apoptosis rate of migrated DC was very 
low,  even  after  8Gy  IR  treatment.  Finally,  we  used 
another positive control of apoptosis DC to confirm 
our theory that apoptosis can inhibit DC migration. 
We used activation induced apoptosis model as our 
positive control of DC and we found that DC treated 
with LPS for about 72h to 96h result in high apoptosis 
rate (Figure 6B), and these cells also show less ability 
to migrate to CCL19 than normal DC treated with LPS 
for 18h to 24h, although they have similar CCR7 ex-
pression  (Figure  6B).  However,  although  PGE2  can 
partly  rescues  the    ray-induced  migratory  impair-
ment of DC and it restores CCR7 expression, exoge-
nous PGE2  have no effect on the apoptosis rate in-
duced  by    ray  (Figure  6C).  Thus,    ray  induced 
apoptosis also participates in DC  migration impair-
ment. 
 
Figure 4. Exogenous PGE2 reduces the  radiation-induced migratory impairment of DC and restores CCR7 ex-
pression. DC were treated with or without  ray irradiation (Dose 0, 2, and 8Gy as indicated, Dose rate: 1Gy/min) with LPS 
(1ug/ml) or LPS (1ug/ml) and PGE2 (1uM) together for 24 hours, then these DC were subjected to an in vitro chemoat-
traction assay to evaluated their migration capacity (A) as described in figure 1 and to be labeled with CCR7-PE antibody for 
detection of the CCR7 positive cell percent by FACS assay (B) as described in figure 2. Relative capacity of PGE2 restoration 
was also calculated (C). (A): Exogenous PGE2 reduces migration inhibition of  radiation treated DC to CCL19. DC was 
exposed to indicated dose of  radiation, stimulated with LPS (1ug/ml) or LPS (1ug/ml) and PGE2 (1uM) together for 24 
hours, and then evaluated for responsiveness to CCL19 by the in vitro chemoattraction assay. (B): Exogenous PGE2 partially 
restores CCR7 expression. DC was exposed to indicated dose of  radiation, stimulated with LPS (1ug/ml) or LPS (1ug/ml) 
and PGE2 (1uM) together for 24 hours, and then be labeled with CCR7-PE antibody for detection of the CCR7 positive cell 
percent by FACS assay. (C): Relative capacity of PGE2 restoration was calculated by the ratio of relative inhibition capacity 
on DC by radiation with Exogenous PGE2 VS. Relative inhibition capacity on DC by radiation without Exogenous PGE2. *: 
P < 0.05. Int. J. Biol. Sci. 2011, 7 
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Figure 5.  radiation induced DC apoptosis in a dose dependent manner. (A/B): DC were treated with different doses( 
as indicated, dose rate: 1Gy/min) of  radiation and then 24 hours later was labeled with annexinV-FITC and PI for detecting 
of apoptosis rate by FACS assay. A showed a representative data of at least three independent experiments. B showed the 
statistical data. (C): DC was treated with different doses of  radiation and then 24 hour later the cell viability of these DC 
was detected by the CCK8 or MTT assay. Data is expressed as mean absorbance ratio at 450nM ±S.D. *: P < 0.05. Int. J. Biol. Sci. 2011, 7 
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Figure 6.  ray induced apoptosis also participates in DC migration impairment. (A): DC were treated with or without 
 ray irradiation (Dose 0, 4 and 8Gy as indicated, Dose rate: 1Gy/min) with LPS (1ug/ml) for 24 hours, then these DC were 
subjected to an in vitro chemoattraction assay. The migrated DC and the DC remained un-migrated were both collected 
and subjected to Apoptosis assay by FACS. Migrated DC and not migrated DC were referring to the result in the in vitro 
chemoattraction assay. (B): Apoptosis rate, migratory ability and CCR7 expression level of DC treated with LPS (1ug/ml) for 
0, 24 or 72hours. Data showed the relative level compared with DC without LPS (LPS 0hour). (C): DC were treated with 
or without  ray irradiation (Dose 0, 2 and 8Gy as indicated, Dose rate: 1Gy/min) with LPS (1ug/ml) or LPS (1ug/ml) and 
PGE2 (1uM) together for 24 hours, then these DC was labeled with annexinV-FITC and PI for detecting of apoptosis rate by 
FACS assay. *: P < 0.05; NS: No Significant difference detected. 
 
 
 
3.5 -ray exposure inhibits DC migration in vivo 
To trace the in vivo migration of the IR-modified 
DC,  1  ×  106  CFSE  labeled  irradiated  or  un-exposed 
control  DCs  were  injected  i.v.  into  C57BL/6  mice. 
Twenty four hours post-injection, the skin of injected 
cite and the draining inguinal LNs (lymph node) were 
dissected and analyzed for the presence of labeled DC 
by flowcytometry. The injected and resident DC were 
identified as CFSE+CD11c+ or CFSE- CD11c+ cells, re-
spectively.  Although,  there  were  no  significant  dif-
ference  between  CFSE-  CD11c+  cells  homed  to  the 
draining inguinal LNs, CFSE+ CD11c+ DC homed to 
the draining inguinal LNs in radiation group is much 
less  than  control  group  (Figure  7),  which  indicates 
that radiation inhibit DC migration in vivo. This data 
indicate that -ray exposure could inhibit DC migra-
tion not only in vitro, but also in vivo. 
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Figure 7 -ray exposure inhibits DC migration in vivo. Day 5 DCs were labeled with CFSE and then treated with 0, 1, 2, 4 
or 8 Gy of IR. Then 10
6 CFSE-labeled DC were injected into C57BL/6 mice. 24 hours later, the injected site of skin and the 
draining inguinal LN (lymph node) were harvested and processed as described previously [17, 24, 25]. Single cell suspensions 
from the draining inguinal LN were prepared, stained with CD11c-PE (eBioscience) and analyzed by FACS described in the 
Materials and Methods. Figure showed statistical data of CD11c and CFSE double positive cell number from the draining 
inguinal LN of C57BL/6 mice injected with different treated DCs. Relative Data are shown as the means ±standard deviation 
from triplicate experiments. *: P < 0.05. 
 
4. Discussion  
It is generally accepted that high doses of ioniz-
ing radiation can cause immunosuppression and it is 
also well known that the leading cause of acute radia-
tion  sickness  is  apoptosis  of  GI  tract  lining  which 
causes  nausea  and  diarrhea  [22,  23,  29].  While,  im-
munosuppression  and  potential  infections  are  also 
important cause of IR induced death [30]. However, 
the influence of ionizing irradiation on the functions 
of DC, the most potent APC, is largely ignored. DC 
migration,  one  critical  step  for  mature  DC-initiated 
immune  response,  is  orchestrated  by  a  complex  in-
terplay between chemokines and their receptors [31]. 
During the differentiation and maturation of DC, se-
quential and orchestrated expressions of chemokine 
receptors are responsible for the proper migration of 
DC to immune sites [15]. Upon DC maturation, up-
regulation of CCR7 will direct immigration of DC into 
the lymph nodes or spleen. The chemokine receptor 
CCR7 and its ligands CCL19 and CCL21 control my-
eloid  DC migration  into different lymphatic  vessels 
and the localization of these DC within LN [17, 20, 21]. 
Our data shows that  radiation exposure can inhibit 
LPS-induced upregulation of CCR7 expression in DC, 
and  accordingly,  gamma  ray-exposed  DC  exhibited 
impaired migration ability to CCL19/MIP-3 in vitro. 
Consistently,  irradiation could also down-regulated 
PGE2 secretion by DC. Our data also shows that ex-
ogenous  PGE2  reduces  the    radiation-induced  mi-
gratory  impairment  of  DC  and  partially  restores 
CCR7  expression.  This  is  consistent  with  results  by 
other groups that exogenous PGE2 can restore CCR7 
expression and migratory capacity reported [20].  
Interestingly, exogenous PGE2 can only partially 
reduce    radiation-induced  migratory  impairment 
and only partly restore CCR7 expression in DC. Fur-
thermore,  we  also  found  that  PGE2  restores  CCR7 
expression much more effectively than rescues of mi-
gratory impairment of DC induced by IR; PGE2 also 
acts more effectively on DC irradiated at 2 Gy than 8 
Gy. These data indicate that the PGE2-CCR7 pathway 
is not the only mechanism of IR induced DC migra-
tion  impairment;  this  is  different  with  other  agents 
that  inhibit  DC  migration  which  only  impairs  the 
CCR7 expression. We also found that IR can induce 
DC apoptosis and inhibit DC viability in a dose de-
pendent manner. Although this part maybe not a [32] 
totally new finding, our data also suggests that  ra-
diation  induced  apoptosis  also  participates  in  DC 
migration impairment. 
This mechanism of inhibitory effect by IR on DC 
migration, due to DC apoptosis and down-regulation 
of CCR7 expression, is important because we can't just 
protect DC from cell death or CCR7 down-regulation 
on    ray-medicated  DC  migration  defects,  we  must 
take into account the two pathways. 
Our data indicate that -ray exposure could in-
hibit DC migration not only in vitro, but also in vivo. 
This is very important because the importance of DC Int. J. Biol. Sci. 2011, 7 
 
http://www.biolsci.org 
178 
in immune regulation. Studies also show that one of 
the  major  immunological  concerns  about  radiation 
induced  cell  death  is  the  increased  production  of 
transforming growth factor-b (TGF-). In fact, Ioniz-
ing radiation has been shown to release TGF- in vitro 
and  in  vivo  [32].  In  normal  tissues  TGF-  leads  to 
growth  inhibition,  apoptosis,  and  serve  as  a  tumor 
suppressor gene [33]. However, TGF- expression is 
often increased in many tumors and it can play some 
oncogene like function [34]. In our system, PGE2 and 
IL10 production by DC were also been found to be 
significantly inhibited by  ray; However, we didn’t 
found    ray  can  significantly  inhibit  or  enhance 
LPS-induced  TGF-  production  by  DCs  by  using 
ELISA assay (data not shown). Maybe our system is a 
little different from previous studies and we will ex-
plore this issue later. 
In our current study, IL-10 has been found to be 
reduced  by  irradiation.  It  is  true  that  IL-10  is  well 
known  for  immunosuppression  function  [1,  11]. 
However, studies also show that IL-10 may play im-
portant  role  in  killing  acute  influenza  virus  [35]. 
Therefore, our data indicates that IL-10 may not play 
important  role  in  radiation  induced  migration  im-
pairment of DCs. However, it will play immunosup-
presing roles in other process.  
In summary, our results demonstrate that  ra-
diation potently inhibits LPS-triggered CCR7 expres-
sion and induces apoptosis of DC, leading to the im-
paired DC migration to CCL19 in vitro and in vivo. 
The DC migration impaired by gamma ray exposure 
may be partly prevented by exogenous PGE2. These 
results provide an important mechanistic insight into 
 radiation medicated immunosuppression. 
Acknowledgment 
We thank Dr. Cindy Savage & Dr. Trip Barthel 
for critically reading of the manuscript. Special thanks 
to Dr. Xuetao Cao from National Key Laboratory of 
Medical Immunology and Dr. Pu You from depart-
ment of cell biology of our university for providing 
additional helps. We wish to thank Dr. Min Li from 
the department of hygienics of our university for do-
ing the q-RT-PCR assays.  
Funding: This work was supported in part by 
the grants from National Natural Science Foundation 
of  China  (No.  30970679;  No.  31070762  &  No. 
81001221). The funders had no role in study design, 
data collection and analysis, decision  to publish,  or 
preparation of the manuscript. 
Conflict of Interests 
The authors have declared that no conflict of in-
terest exists. 
References 
1.  Banchereau J and Steinman R.M. Dendritic cells and the control 
of immunity. Nature, 1998. 392(6673): 245-52. 
2.  Zitvogel L. Dendritic and natural killer cells cooperate in the 
control/switch of innate immunity.  J  Exp  Med,  2002.  195(3): 
F9-14. 
3.  Banchereau  J,  et  al.  Immunobiology  of  dendritic cells.  Annu 
Rev Immunol, 2000. 18: 767-811. 
4.  Lanzavecchia A and Sallusto F. Regulation of T cell immunity 
by dendritic cells. Cell, 2001. 106(3): 263-6. 
5.  Garg S, et al. Genetic tagging shows increased frequency and 
longevity of antigen-presenting, skin-derived dendritic cells in 
vivo. Nat Immunol, 2003. 4(9): 907-12. 
6.  Mellman I and Steinman R.M. Dendritic cells: specialized and 
regulated antigen processing machines. Cell, 2001. 106(3): 255-8. 
7.  Zhang  Z,  et  al.  Differential  restoration  of  myeloid  and 
plasmacytoid  dendritic  cells  in  HIV-1-infected  children  after 
treatment with highly active antiretroviral therapy. Immunol J, 
2006. 176(9): 5644-51. 
8.  Allan  R.S,  et  al.  Epidermal  viral  immunity  induced  by 
CD8alpha+ dendritic cells but not by Langerhans cells. Science, 
2003. 301(5641): 1925-8. 
9.  Shlomchik W.D, et al. Prevention of graft versus host disease by 
inactivation  of  host  antigen-presenting  cells.  Science,  1999. 
285(5426): 412-5. 
10.  Tacken P.J, et al. Dendritic-cell immunotherapy: from ex vivo 
loading  to  in  vivo  targeting.  Nat  Rev  Immunol,  2007.  7(10): 
790-802. 
11.  Hackstein  H  and  Thomson  A.W.  Dendritic  cells:  emerging 
pharmacological targets of immunosuppressive drugs. Nat Rev 
Immunol, 2004. 4(1): 24-34. 
12.  Merad M, et al. Langerhans cells renew in the skin throughout 
life under steady-state conditions. Nat Immunol, 2002. 3(12): 
1135-41. 
13.  Naik S.H, et al. Development of plasmacytoid and conventional 
dendritic cell subtypes from single precursor cells derived in 
vitro and in vivo. Nat Immunol, 2007. 8(11): 1217-26. 
14.  Onai  N,  et  al.  Identification  of  clonogenic  common 
Flt3+M-CSFR+  plasmacytoid  and  conventional  dendritic  cell 
progenitors in mouse bone marrow. Nat Immunol, 2007. 8(11): 
1207-16. 
15.  Faure-Andre G, et al. Regulation of dendritic cell migration by 
CD74,  the  MHC  class  II-associated  invariant  chain.  Science, 
2008. 322(5908): 1705-10. 
16.  Randolph G.J. Dendritic cell migration to lymph nodes: cyto-
kines, chemokines, and lipid mediators. Semin Immunol, 2001. 
13(5): 267-74. 
17.  Ohl L, et al. CCR7 governs skin dendritic cell migration under 
inflammatory  and  steady-state  conditions.  Immunity,  2004. 
21(2): 279-88. 
18.  Forster  R,  et  al.  CCR7  coordinates  the  primary  immune  re-
sponse  by  establishing  functional  microenvironments  in  sec-
ondary lymphoid organs. Cell, 1999. 99(1): 23-33. 
19.  Kabashima  K,  et  al.  Prostaglandin  E2-EP4  signaling  initiates 
skin immune responses by promoting migration and matura-
tion of Langerhans cells. Nat Med, 2003. 9(6): 744-9. 
20.  Scandella E, et al. Prostaglandin E2 is a key factor for CCR7 
surface  expression  and  migration  of  monocyte-derived  den-
dritic cells. Blood, 2002. 100(4): 1354-61. Int. J. Biol. Sci. 2011, 7 
 
http://www.biolsci.org 
179 
21.  Scandella E, et al. CCL19/CCL21-triggered signal transduction 
and  migration  of  dendritic  cells  requires  prostaglandin  E2. 
Blood, 2004. 103(5): 1595-601. 
22.  Vrijheid M, et al. Ionizing radiation and risk of chronic lym-
phocytic leukemia in the 15-country study of nuclear industry 
workers. Radiat Res, 2008. 170(5): 661-5. 
23.  Burdelya L.G, et al. An agonist of toll-like receptor 5 has radi-
oprotective  activity  in  mouse  and  primate  models.  Science, 
2008. 320(5873): 226-30. 
24.  Zhang M, et al. Splenic stroma drives mature dendritic cells to 
differentiate into regulatory dendritic cells. Nat Immunol, 2004. 
5(11): 1124-33. 
25.  Chen T, et al. Cyclosporin A impairs dendritic cell migration by 
regulating  chemokine  receptor  expression  and  inhibiting  cy-
clooxygenase-2 expression. Blood, 2004. 103(2): 413-21. 
26.  Fu Z, et al. Expression changes of ERK1/2, STAT3 and SHP-2 in 
bone marrow cells from gamma-ray induced leukemia mice. J 
Radiat Res (Tokyo), 2006. 47(2): 121-30. 
27.  Qian L, et al. Radioprotective effect of hydrogen in cultured 
cells and mice. Free Radic Res, 2010. 44(3): 275-82. 
28.  Qian L, et al. The potential cardioprotective effects of hydrogen 
in irradiated mice. J Radiat Res (Tokyo), 2010. 51(6): 741-7. 
29.  Ward  J.F.  DNA  damage  produced  by  ionizing  radiation  in 
mammalian  cells:  identities,  mechanisms  of  formation,  and 
reparability. Prog Nucleic Acid Res Mol Biol, 1988. 35: 95-125. 
30.  Kalpana K.B, et al. Investigation of the radioprotective efficacy 
of hesperidin against gamma-radiation induced cellular dam-
age in cultured human peripheral blood lymphocytes. Mutat 
Res, 2009. 676(1-2): 54-61. 
31.  Merad M, Ginhoux F., and Collin M. Origin, homeostasis and 
function  of  Langerhans  cells  and  other  langerin-expressing 
dendritic cells. Nat Rev Immunol, 2008. 8(12): 935-47. 
32.  Barcellos-Hoff  M.H,  et  al.  Transforming  growth  factor-beta 
activation in irradiated murine mammary gland. J Clin Invest, 
1994. 93(2): 892-9. 
33.  Derynck R, Akhurst R.J., and Balmain A. TGF-beta signaling in 
tumor suppression and cancer progression. Nat Genet, 2001. 
29(2): 117-29. 
34.  Bachman K.E and Park B.H. Duel nature of TGF-beta signaling: 
tumor suppressor vs. tumor promoter. Curr Opin Oncol, 2005. 
17(1): 49-54. 
35.  Sun J, et al. Effector T cells control lung inflammation during 
acute influenza virus infection by producing IL-10. Nat Med, 
2009. 15(3): 277-84. 